MedPath
TGA Approval

ERBITUX cetuximab (rmc) 500mg/100mL solution for intravenous infusion (132396)

132396

ERBITUX cetuximab (rmc) 500mg/100mL solution for intravenous infusion

Merck Healthcare Pty Ltd

September 25, 2007

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-01424-3

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-01421-3

Active Ingredients

Cetuximab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.